Latest Continuous Disclosure News

FirstWave Cloud Technology acknowledged the material nature of cash and revenue figures disclosed during a shareholder webinar and affirmed compliance with ASX continuous disclosure rules, while committing to improved timing of market announcements.

SRJ Technologies Group clarified that no undisclosed material information explains its recent share price surge, pointing instead to earlier BoltEx orders and the recent SpaceX IPO as likely influences.

Helios Energy has raised $1.5 million through a share placement priced at $0.003 per share while extinguishing $100,000 of convertible note debt by issuing shares, bolstering working capital.

Spenda Limited (ASX: SPX) has voluntarily suspended trading of its shares from 2 June 2026 to manage disclosure around its institutional accelerated renounceable entitlement offer (AREO). The suspension is expected to last until 10 June or until the AREO results are announced.

The a2 Milk Company (ASX:A2M) has denied any undisclosed material information following a sharp share price drop and increased trading volumes, attributing market moves to a recent analyst downgrade citing supply chain uncertainties.

a2 Milk confirms no undisclosed information behind recent share price moves, attributing volatility to a CLSA downgrade citing supply delays and previously disclosed risks.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.

IDP Education (ASX:IEL) has responded to an ASX price query following a sharp share price fall and increased trading volume, attributing the movement to a late analyst downgrade and confirming compliance with continuous disclosure rules.

Bass Oil Limited offers up to 24 million free attaching options to recent placement participants, alongside nearly 8 million options to its lead manager PAC Partners, with no new funds raised from the options issue.

Immuron Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information but pointing to a recent CEO presentation as a possible driver.

Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.

Li-FT Power Ltd. has released an extensive update to its Corporate Governance Statement, outlining its board structure, committee roles, and compliance with Canadian and ASX governance standards. The company highlights partial adherence to some ASX recommendations, reflecting its current development stage.